
New technologies and adaptations of existing technologies can improve platform processes.
Judy Glynn is senior principal scientist at Pfizer Global Research and Development Global Biologics, Bioprocess R&D

New technologies and adaptations of existing technologies can improve platform processes.

A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.

A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.

If certain engineering challenges can be addressed, precipitation may prove to be a valuable tool for antibody purification.

Published: March 2nd 2010 | Updated:

Published: October 2nd 2009 | Updated:

Published: March 2nd 2009 | Updated:

Published: March 2nd 2008 | Updated: